Timothy M Adams
CIK 1298669 · Chief Financial Officer · last filed 2026-09-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ATHN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WATERTOWN, MA 02472
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SSTK | Director | — | $4.59 | — | $0 | 1 | 2026-09-10 |
| RPD | Chief Financial Officer | 186,863 | $14.91 | $2.79M | -$475.9K | 16 | 2025-11-17 |
| MODEL N, INC. (MODN) Delisted | Director | 0 | $30.00 | $0 | -$1.50M | 20 | 2024-06-27 |
| Prevail Therapeutics Inc. (PRVL) Delisted | Director | — | — | — | $0 | 1 | 2020-06-19 |
| Demandware Inc (DWRE) Delisted | See Remarks | 55,425 | — | — | -$584.3K | 8 | 2016-07-11 |
| ATHENAHEALTH INC (ATHN) Delisted | CFO & SVP | 39,526 | $9.59 | $379.1K | -$10.05M | 15 | 2014-03-05 |
| OFIX | Chief Financial Officer | — | $9.81 | — | $0 | 2 | 2008-05-01 |
| CYTYC CORP (CYTC) Delisted | Chief Financial Officer | 619,720 | — | — | -$9.37M | 18 | 2007-09-26 |
Recent Filings · Page 4 of 9
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-12 | MODEL N, INC. (MODN) Delisted | Sell (S) | −8,119 | -$320.4K | EDGAR |
| 2020-09-15 | MODEL N, INC. (MODN) Delisted | Mixed | −5,255 | -$166.9K | EDGAR |
| 2020-06-19 | Prevail Therapeutics Inc. (PRVL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-19 | MODEL N, INC. (MODN) Delisted | Grant (A) | +124 | $0 | EDGAR |
| 2020-02-14 | MODEL N, INC. (MODN) Delisted | Grant (A) | +4,870 | $0 | EDGAR |
| 2019-02-15 | MODEL N, INC. (MODN) Delisted | Grant (A) | +13,957 | $0 | EDGAR |
| 2018-02-21 | MODEL N, INC. (MODN) Delisted | Grant (A) | +9,260 | $0 | EDGAR |
| 2017-11-07 | MODEL N, INC. (MODN) Delisted | Grant (A) | +280 | $0 | EDGAR |
| 2017-02-17 | MODEL N, INC. (MODN) Delisted | Grant (A) | +14,739 | $0 | EDGAR |
| 2016-12-28 | MODEL N, INC. (MODN) Delisted | Grant (A) | +2,349 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.